125 mg

DRUG2 trials

Sponsors

Stichting Radboud University Medical Center, University Of Tartu

Conditions

Non-medullary thyroid Carconoma (NMTC)Postoperative nausea and vomiting

Phase 2

Digoxin for the Reinduction or Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma.

CompletedCTIS2022-500477-14-00

Stichting Radboud University Medical CenterNon-medullary thyroid Carconoma (NMTC)

Start: 2022-11-09End: 2023-06-21Target: 10Updated: 2023-02-09

Phase 4

The efficacy of aprepitant for the prevention of postoperative nausea and vomiting after bariatric surgery.

Active, not recruitingCTIS2023-508849-40-00

University Of TartuPostoperative nausea and vomiting

Start: 2024-04-11Target: 260Updated: 2025-01-07